For those who have panic selling , you can still make amend for your mistakes by re-buying now but remember the three golden rules........ *rule no.1- never panic selling , *rule no.2 - same as rule no.1 and; *rule no.3- same as rule no.2..........
hi rr88.. paktua save yer.. ============== rr88 @Solution chart says it has already crashed. Now technical rebound in midway of crash. Solution will drop 0.40++ tomorrow. Bintai will drop 0.30++. Dump it all n stay away from all these con stocks. 09/12/2020 11:13 AM =============== if not reach let paktua know yer.. kita jumpa KJ kasi cukur dia janggut hehe
Dato send a message to all of you.. Good news coming soon for the Vaccine acquisition of license in Msia.. Do not simply dump your tickets because of some Naysayers..
assume 10% population wants private hospital covid 19, one pax make rm30 say
only 3.6m population wants covid 19 from private hospital, RM100m profit dividend by solution/ bintai/ kanger/ myeg/ other wannabes - divided by 2 years
bintai at least can make rm5m next year - pe of 90x, dont sell wait when?
poor paktua kena bash together with bintai from these strangers yesterday (all sarcastically using his "tut tut" signoff.) eh, kesian him la.. all he did was share some poems and his point of view. if you don't like his advice then just don't follow... can debate but don't like until attack with insults only. yesterday so many ppl bash him like it's his fault bintai went down (no class ppl). today you see? all shut up already. i'm not following paktua's advice personally, but it's sad to see bullying like this. you guys are supposed to be adults... all the young, first-time investors come here and read the comments then don't want to invest in bursa. scared become pontianak bursa like you all!
whoever sold this morning and yesterday now regretting. just listen to yourself la. wanna debate don't get so emotional la... it will save us a lot of time scrolling pass the insults to get to some real info.
imho , only 2 vaccine stock can buy, bintai and hwgb,both is cos of the technology of the vaccine, bintai also have distributorship from SEA to australia/ NZ - thats a huge market nad infact China CDC is also pump money into generex..if china so confident of their own tech, why wanna dump money into generex?.. Also HWGB is using polio vaccine thats been around 70 years and they r doing 4th phase now..polio vaccine have long record of safety..i would be scared of china vaccines sinopharm, sinovac, all china produce vaccine is not going 3rd phase trial yet.. and even so the data can be trusted? for pfizer and moderna..i feel this new technology that messes with our DNA can cos problems in the future..the risk is high and logisticall requirement are at -70degC --- seriously?? hahaha..what if the vaccine simply 30min in the lorry no aircond..who knows if the vaccine is safe for longterm due to some variation to its condition. cansino vaccine also is funny, the result from cansino vaccine show many side effects - but china still approved it for its military use..i read cansino vaccine is similar tech to russia vaccine.. so i really doubt the safety..this my opinion
USFDA had released a 53-page report on Pfizer's late stage trial. 6 patients died (2 vaccinated and 4 on placebo). It concluded that the efficacy data met its expectation for emergency use. Logic thinking will tell you, even if you wear full PPE outside, it will not 100% protect you from not getting Covid. I mean, even when you wear condom, the data tell you that she may still get pregnant. So if you want a perfect scoring, you probably still sleeping and dreaming. Wake up and smell the coffee
47 workers test positive for Covid in Uganda despite Chinese vaccine 47 Chinese workers test positive for coronavirus in Uganda despite receiving vaunted vaccine 13110 By Keoni Everington, Taiwan News, Staff Writer 2020/12/08 16:59
TAIPEI (Taiwan News) — Despite being inoculated with China's vaunted coronavirus vaccines, 47 Chinese workers in Uganda have been diagnosed with the virus, raising questions about the efficacy of the China-made products.
Back in July, long before clinical trials had been completed (currently in Phase Three), two candidates by Sinopharm's subsidiary China National Biotec Group Company Limited (CNBG) and one by Sinovac Biotech SVA.O were given the green light to be injected into "essential workers" as part of an emergency use program that began that month. As of November, the experimental vaccines had been administered to one million people in China.
The recipients of the vaccines have included Chinese citizens preparing to travel overseas, including diplomats, students, and at least 56,000 construction workers from state-run enterprises. In November, Reuters cited Sinopharm as boasting that none of its vaccine recipients who went abroad had been infected.
However, the Chinese Embassy in Uganda on Dec. 5 announced that an Indian company in Uganda reported 47 Chinese citizens working for the firm had tested positive for COVID-19. It stated the majority of the cases were asymptomatic, but "a minority" experienced symptoms of the virus, including fever, cough, fatigue, and diarrhea.
The embassy reminded overseas Chinese and Chinese-funded institutions in Uganda to take all necessary measures to prevent cluster infections. Given that the workers had been recently dispatched from China, they should have received one of the three experimental vaccines in advance.
The fact that 47 workers in one company tested positive for the virus and an undisclosed number exhibited symptoms casts doubts on the efficacy of the experimental Chinese vaccines. Although the Chinese biotech industry claims that large-scale vaccinations have been carried out in accordance with emergency use regulations and are safe and effective, experts point out that the very low "official" rate of coronavirus infections in China after May and lack of data on those vaccinated fail to support these assertions.
During an interview in August, Sinopharm Group Chairman Liu Jingzhen (劉敬楨) declared that Chinese-made vaccines will be available by the end of the year. He claimed that one dose would only cost a few hundred Chinese yuan and would be 100 percent effective; in comparison, efficacy rates of the candidates by Pfizer, Moderna, and Astra Zeneca in Phase Three trials are 95 percent, 94.5 percent, 70 percent, respectively.
please see history.. taiwan will condemned all china related.. paktua never trust taiwan new if related china.. also same nver trust new china if related to taiwan want concrete WHO new update
UAE’s health ministry officially registers Sinopharm COVID-19 vaccine
The UAE’s Ministry of Health and Prevention (MOHAP), has officially registered Beijing Institute of Biological Product’s inactivated COVID-19 vaccine as part of its efforts to combat the global pandemic.
The vaccine was registered upon request of Sinopharm CNBG.
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
yuntung
6 posts
Posted by yuntung > 2020-12-09 11:26 | Report Abuse
brp entry price. can someone guide me